Evidence map›Paper›PMID 40021838›Full record

ArticleScientific reports2025

Integrating convolutional layers and biformer network with forward-forward and backpropagation training.

Ali Kianfar, Parvin Razzaghi, Zahra Asgari

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ali KianfarDepartment of Computer Science and Information Technology, Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran.ORCID http://orcid.org/0009-0009-2817-3601
Parvin RazzaghiDepartment of Computer Science and Information Technology, Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran. p.razzaghi@iasbs.ac.ir.ORCID http://orcid.org/0000-0002-7031-4609
Zahra AsgariSchool of Life Science Engineering, College of Interdisciplinary Science and Technology, University of Tehran, Tehran, Iran.ORCID http://orcid.org/0000-0002-9781-3483

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate molecular property prediction is crucial for drug discovery and computational chemistry, facilitating the identification of promising compounds and accelerating therapeutic development. Traditional machine learning falters with high-dimensional data and manual feature engineering, while existing deep learning approaches may not capture complex molecular structures, leaving a research gap. We introduce Deep-CBN, a novel framework designed to enhance molecular property prediction by capturing intricate molecular representations directly from raw data, thus improving accuracy and efficiency. Our methodology combines convolutional neural networks (CNNs) with a BiFormer attention mechanism, employing both the forward-forward algorithm and backpropagation. The model operates in three stages: (1) feature learning, extracting local features from SMILES strings using CNNs; (2) attention refinement, capturing global context with a BiFormer module enhanced by the forward-forward algorithm; and (3) prediction subnetwork tuning, fine-tuning via backpropagation. Evaluations on benchmark datasets-including Tox21, BBBP, SIDER, ClinTox, BACE, HIV, and MUV-show that Deep-CBN achieves near-perfect ROC-AUC scores, significantly outperforming state-of-the-art methods. These findings demonstrate its effectiveness in capturing complex molecular patterns, offering a robust tool to accelerate drug discovery processes.

Indexed as

Deep LearningDrug DiscoveryNeural Networks, ComputerAlgorithmsHumansBiFormer attention mechanismConvolutional neural networksDeep learningDrug discoveryMolecular property prediction

Identifiers

PMID40021838
PMCPMC11871031

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.